腹膜监测
Monitoring of the peritoneal membrane.
作者信息
Struijk Dirk G
机构信息
Dianet Foundation, Amsterdam, Utrecht , The Netherlands.
出版信息
NDT Plus. 2008 Oct;1(Suppl 4):iv29-iv35. doi: 10.1093/ndtplus/sfn121.
Abstract
Background. Indirect methods can be used to provide valuable information about peritoneal structure and function for the indirect analysis of peritoneal membrane. Methods. The focus of this paper will be on the commonly available tools for this purpose. First, the value and clinical relevance of CA125 as a marker of mesothelial cell mass in peritoneal effluent will be evaluated. Thereafter, monitoring the peritoneal membrane by using its properties to transport solutes and water will be discussed. Results. The data obtained can be useful for tailoring dialysis adequacy, analysis of clinical problems such as ultrafiltration failure or to predict the development of peritoneal sclerosis.
摘要
背景。间接方法可用于提供有关腹膜结构和功能的有价值信息，以对腹膜进行间接分析。方法。本文重点将放在为此目的常用的工具上。首先，将评估CA125作为腹膜透析液中间皮细胞量标志物的价值和临床相关性。此后，将讨论利用腹膜转运溶质和水的特性来监测腹膜。结果。所获得的数据可有助于调整透析充分性、分析诸如超滤失败等临床问题或预测腹膜硬化的发展。
相似文献
1
Monitoring of the peritoneal membrane.
NDT Plus. 2008 Oct;1(Suppl 4):iv29-iv35. doi: 10.1093/ndtplus/sfn121.
2
Overnight mesothelial cell exfoliation: a magic tool for predicting future ultrafiltration failure in patients on continuous ambulatory peritoneal dialysis.
Perit Dial Int. 2008 Jun;28 Suppl 3:S107-13.
3
Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients.
Ther Apher Dial. 2016 Apr;20(2):149-57. doi: 10.1111/1744-9987.12391. Epub 2016 Mar 1.
4
Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis.
Perit Dial Int. 2001 Nov-Dec;21(6):560-7.
5
Dialysate cancer antigen 125 in long-term peritoneal dialysis patients.
Clin Exp Nephrol. 2014 Feb;18(1):10-5. doi: 10.1007/s10157-013-0823-7. Epub 2013 Jun 12.
6
Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis.
Perit Dial Int. 2001 Sep-Oct;21(5):495-500.
7
Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcome.
Adv Perit Dial. 1999;15:36-9.
8
Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
Am J Kidney Dis. 1997 May;29(5):699-705. doi: 10.1016/s0272-6386(97)90122-0.
9
Influence of dialysis duration, peritoneal transport parameters, and gender on effluent CA125 concentration in patients on peritoneal dialysis.
Iran J Kidney Dis. 2007 Oct;1(2):78-81.
10
The Association of Effluent Ca125 with Peritoneal Dialysis Technique Failure.
Perit Dial Int. 2015 Dec;35(7):683-90. doi: 10.3747/pdi.2014.00016. Epub 2015 Jul 7.
引用本文的文献
1
A systematic review of the cost-effectiveness of renal replacement therapies, and consequences for decision-making in the end-stage renal disease treatment pathway.
Eur J Health Econ. 2023 Apr;24(3):377-392. doi: 10.1007/s10198-022-01478-2. Epub 2022 Jun 18.
2
Peritoneal Transport Characteristics at the Beginning and in Long Term Peritoneal Dialysis: a Single Center Experience.
Mater Sociomed. 2020 Jun;32(2):99-104. doi: 10.5455/msm.2020.32.99-104.
3
Unraveling Hepcidin Plasma Protein Binding: Evidence from Peritoneal Equilibration Testing.
Pharmaceuticals (Basel). 2019 Aug 23;12(3):123. doi: 10.3390/ph12030123.
4
Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017.
本文引用的文献
1
Peritoneal dialysis: a clinical study of factors governing its effectiveness. 1959.
Kidney Int Suppl. 2008 Apr(108):S5-S17. doi: 10.1038/sj.ki.5002633.
2
Overfill of peritoneal dialysis bags as a cause of underestimation of ultrafiltration failure.
Perit Dial Int. 2006 Jul-Aug;26(4):503-5.
3
Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.
Clin Exp Nephrol. 2005 Dec;9(4):315-319. doi: 10.1007/s10157-005-0384-5.
4
Do interleukin-6, hyaluronan, soluble intercellular adhesion molecule-1 and cancer antigen 125 in dialysate predict changes in peritoneal function? A 1-year follow-up study.
Scand J Urol Nephrol. 2005;39(5):410-6. doi: 10.1080/00365590500386809.
5
Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?
Perit Dial Int. 2005 Sep-Oct;25(5):453-60.
6
Limitations of CA125 as an index of peritoneal mesothelial cell mass.
Nephron Clin Pract. 2005;100(2):c46-51. doi: 10.1159/000085032. Epub 2005 Apr 7.
7
Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
J Nephrol. 2005 Jan-Feb;18(1):67-71.
8
Accuracy of ultrafiltration volume measurements for patients on peritoneal dialysis.
Perit Dial Int. 2005 Jan-Feb;25(1):92-3.
9
Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.
Perit Dial Int. 2004 Nov-Dec;24(6):554-61.
Zotero 插件